Featured News
Empower Your Gene Therapy Research and Ignite the Path to Development Breakthroughs
Leverage a complete concept-to-cure gene therapy portfolio and decades of experience
The research phase of gene therapy development comes with its own set of challenges. Organizations and academic institutions ready to start putting their blueprint plans into action are in need of products and services to streamline an already complex scenario.
With a phase-appropriate approach in mind, our recombinant adeno-associated virus (AAV), lentivirus viral vector (LVV) services, as well as royalty-free plasmid DNA products streamline your gene therapy from discovery to commercial manufacture, supporting every phase in between. Invest in your gene therapy early by selecting the right construct from the beginning and move seamlessly through discovery and preclinical testing phases with the end in mind.
All our products are manufactured in either the United States or the United Kingdom, ensuring flexibility throughout the end-to-end process for all gene therapy developers. Your therapies are able to leverage the expertise of our trusted custom CDMO Centers of Excellence, compiling your efforts with the support of one partner with over 20 years of cell and gene therapy development experience.
-
CDMO Centers of Excellence
- Plasmid DNA Center of Excellence (Keele and Alderley Park, UK)
Offers custom and standard plasmids with over 10 ISO 7 Grade GMP pDNA production suites. - Viral Vector Manufacturing Center of Excellence (Rockville, MD, USA)
Provides research-grade plasmid and vector products and customized viral solutions. - Cell Therapy GMP Manufacturing Facility (Memphis, TN, USA)
Designed for GMP-compliant manufacturing of cell and gene-modified cell therapies at clinical and commercial scales.
- Plasmid DNA Center of Excellence (Keele and Alderley Park, UK)
Off-the-shelf Plasmids
AAV and LVV Plasmids: For a process that typically takes several months to complete, having plasmids immediately available for use is a game-changer in the fast-paced industry of gene therapies. Our Research Grade (RG), High Quality (HQ), and GMP plasmids are pre-manufactured and fully documented. These AAV and LVV off-the-shelf plasmids save you time and accelerate your gene and cell therapy discovery and development.
Viral Vector Packaging Services
Offering tailored AAV packaging services for every research phase and at multiple scales, our comprehensive testing portfolio prioritizes quality, and includes but is not limited to silver staining, AAV empty/full ratio, endotoxin levels, sterility, and mycoplasma. This ensures you receive stable, pure, high-yield viral vectors, optimizing performance for superior therapeutic results.
A clear look at the full picture:
- Comprehensive gene therapy products and services portfolio
- Premium quality offering leveraging CDMO centers of excellence
- Supports a seamless transition to clinic and commercial
- Trusted partnership to empower your gene therapy research
Preparing Your Gene or Gene-Modified Cell Therapy for IND Filing
Scaling up both manufacturing programs and processes of gene and gene-modified cell therapies presents significant challenges. In this webinar our experts discuss meeting regulatory requirements from the very beginning, as well as other key development considerations.
Watch now